You can use your existing Medical Independent, MediLearning or PharmacistCPD account to log in.


Medicalindependent.ie is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.


The benefits of registering: only registered users:
  • receive the ecCopy two days prior to the printed edition.
  • have automatic access to our free CPD sites.
  • can partake in our online MCQs.
  • can enter our online sports quiz.

Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

Download the new Mindo app for both IOS & Android.

  • Get notified when a story goes live
  • Access Premium Content
  • Read Offline
 
[the_ad_placement id="main-ldb-public"]
[the_ad_placement id="main-ldb-mobile-public"]

You are reading 1 of 2 free-access articles allowed for 30 days

HIQA recommends a minimally-invasive alternative to open heart surgery

By Dermot - 05th Dec 2019 | 3 views

The Health Information and Quality Authority (HIQA) has published a health technology assessment (HTA) recommending that the Minister for Health and the HSE consider extending transcatheter aortic valve implantation (TAVI)  to patients with severe symptomatic aortic stenosis at intermediate and low risk of surgical complications.

TAVI is described by HIQA as “a minimally-invasive alternative to open heart surgery”.

Currently TAVI is primarily offered as an alternative to surgical aortic valve replacement (SAVR) in patients that are otherwise inoperable or at high risk of surgical complications.

 “Clinical trials have demonstrated that TAVI is just as safe as SAVR in terms of cardiac and all-cause mortality,” said HIQA’s Chief Scientist, Dr Conor Teljeur.

“Although some other complications differ between TAVI and SAVR, the minimally invasive procedure is associated with a shorter length of stay in hospital and improved health-related quality of life gains in the short term (up to three months) compared with open heart surgery.”

Between 3 per cent and 4 per cent of adults aged 75 years and older have severe aortic stenosis, of which three-quarters are symptomatic

Leave a Reply

[the_ad_placement id="main-ldb-public-2"]
[the_ad_placement id="main-ldb-mobile-public-2"]
Latest Issue
The Medical Independent – 24 June 2021

You need to be logged in to access this content. Please login or sign up using the links below.

[the_ad_placement id="main-mpu-public"]
Most Read
[the_ad_placement id="main-ldb-public-2"]
[the_ad_placement id="main-ldb-mobile-public-2"]